Has Nagesh Shetty, MD received payments from drug or device companies?

Yes. Drug and device makers reported $13,453 in general payments to Nagesh Shetty, MD across 27 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nagesh Shetty, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nagesh Shetty, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nagesh Shetty, MD

Cardiovascular Disease · Woodland Hills, CANPI 1952466245

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $11,900 of the $13,453 with a category attached, or 88.5%. Edwards Lifesciences accounts for 88.5% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $12,490 and has fallen 99.7% since, to $40 in 2024.

$13,453in general payments, 2019–2025

Across 27 payments — averaging $498.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Edwards Lifesciences$12K
AstraZeneca$333
Biohaven Pharmaceuticals, Inc.$251
Amgen$149
Boehringer Ingelheim$136
GSK$120
plus $564 from 7 others

What the payments were for

Consulting fees$11,90088%
Food & beverage$1,44611%
Other$1071%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Edwards Lifesciences	7	$11,900
AstraZeneca	3	$333
Biohaven Pharmaceuticals, Inc.	2	$251
Amgen	2	$149
Boehringer Ingelheim	2	$136
GSK	1	$120
Lilly USA, LLC	1	$115
Baxter Healthcare	1	$107
Gilead	1	$100
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$88
Boston Scientific	3	$87
Novartis	2	$48
Johnson & Johnson	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,453 in reported general payments places this provider in the 80th percentile of 2,184 cardiovascular disease providers in California.

See all cardiovascular disease providers in California →

Medicare billing

Part B allowed, 2024

$15,851

Medicare patients

Services billed

183

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	13	$2,913
Mometasone Furoate	11	$548
Albuterol Sulfate HfaAlbuterol Sulfate	13	$378
Amlodipine Besylate	13	$264
Montelukast Sodium	13	$36
Prednisone	12	$20

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Woodland Hills

Ted LoveHillsborough$102.8M
Paul KurthSanta Barbara$6.1M
Jason RogersSacramento$4.4M
Matthew BudoffTorrance$3.6M
Eric Topolla Jolla$2.2M
Cathleen Bairey-MerzLos Angeles$1.2M
Gagan SinghSacramento$1.2M
Pam Taubla Jolla$1.2M
Wilber SuStanford$1.1M
Thomas SmithSacramento$942K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →